Mistake 7: Storing drops improperly Compounded GLP-1 drops are sensitive to temperature
A 1200-calorie day with very little protein is not the same as a 1400-calorie day with protein spread across meals
Key Takeaways In the Phase 3 TRIUMPH-1 trial (2026), retatrutide 12 mg produced an average 28.3% body-weight reduction at 80 weeks, with 45.3% of participants losing 30% or more ( New England Journal of Medicine / Eli Lilly, 2026 )
Importantly, ColonBroom GLP-1 Booster is not a drug, hormone, or prescription medication , and it does not contain liraglutide, semaglutide, or other pharmaceutical GLP-1 agonists
For people who want to explore other injectable options for weight management, resources like the Saxenda vs Ozempic comparison can provide added perspective on what is available
This central action contributes to weight loss by reducing hunger and caloric intake